Ceramide-induced mitophagy impairs SS-oxidation-linked energy production in PINK1 deficiency

Mitophagy and energy production are two functionalities in which PINK1 plays a key role. Loss of PINK1 is one of the genetic causes of Parkinson disease (PD), suggesting both processes are important in PD pathogenesis. Nonetheless, it remains unclear whether these processes are connected or independent of one another. Sphingolipids, including ceramide, have recently emerged as an important new player in the development of PD, however, how alterations in ceramide levels are mechanistically linked to PD remained elusive. In a recently published study, we demonstrated that ceramide accumulates in mitochondria and initiates ceramide-induced mitophagy, thereby compensating for the lack of PINK1-dependent mitophagy upon PINK1 deficiency. However, ceramide accumulation negatively affects SS-oxidation, further aggravating the electron transport chain (ETC) defect caused by PINK1 deficiency and resulting in an additional requirement for mitophagy. Thus, we showed that ceramide serves as a link between the ETC and mitophagy upon PINK1 deficiency. Interruption of this vicious cycle via stimulation of SS-oxidation or reduction of ceramide levels can provide a novel therapeutic target in the treatment of PINK1-related PD.

Automated summary

PINK1 plays a critical role in the pathogenesis of Parkinson's disease, connecting to both mitophagy and energy production. Accumulation of ceramide in mitochondria triggers ceramide-induced mitophagy, while negatively affecting SS-oxidation.